Updated March 4 at 7:04pm
Technology
563 results total, viewing 481 - 490
Given that the computing power that once required a warehouse of processing units can now be put into smartphones, it’s difficult to believe that competition to miniaturize mechanical electronic components is still on. But it is. more
The brainchild of cousins Dave Evans and Charlie Dewey, the Evans Capacitor Co. in East Providence has been inventing, developing and producing unique, high-energy, density capacitors since it opened its doors in 1996. Today, Evans Capacitor’s hybrid capacitors have established a niche for very high-power, high-reliability pieces with aerospace and defense applications. more
Isaac Newton left something out when he wrote down his theories on gravity: it can hurt. more
Betaspring hosted more than 300 community supporters, investors and Betaspring alumni Thursday for an open house introducing the accelerator’s spring 2014 class of startups. more
Global biotech firm Covidien PLC reported Friday that its net income rose five-tenths of a percent in its fiscal second quarter, totaling $441 million, or 97 cents per diluted share, compared with $439 million, or 92 cents per diluted share, during the same period a year earlier. more
The R.I. Coastal Resources Management Council will meet on Tuesday, May 13, to vote on whether to grant final approval to Deepwater Wind LLC’s proposed wind farm project. more
Rhode Island boasted the eighth-fastest average Internet connection speed in the United States during the fourth quarter of 2013, according to the “State of the Internet” report released Wednesday by cloud services firm Akamai Technologies Inc. more
A biologist and theologian at Providence College has been awarded a major national health grant to support research of a gene linked to several human cancers. more
General Electric Co. is in talks to buy Alstom SA, the French builder of trains and power plants, people with knowledge of the matter said, in what would be GE’s biggest acquisition ever. more
Amgen Inc., the world’s largest biotechnology company by revenue, disappointed analysts with lower-than-expected sales of its top drug as executives assured investors the drop was seasonal and they were on target to meet their 2014 projections. more
« Prev | 1 46 | 47 | 48 | 49 | 50 | 51 | 52 57 | Next »